The rate of progression in Parkinson's disease:: A [18F]dopa PET study

被引：0
|
作者：
Nurmi, EM
Ruottinen, HM
Bergman, J
Haaparanta, M
Solin, O
Rinne, JO
机构：
来源：
NEUROLOGY | 1999年 / 52卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A91 / A91
页数：1
相关论文
共 50 条
  • [1] Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET
    Hardie, RJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (02): : 256 - 256
  • [2] Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET
    Morrish, PK
    Rakshi, JS
    Bailey, DL
    Sawle, GV
    Brooks, DJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03): : 314 - 319
  • [3] Rate of progression in Parkinson's disease:: A 6-[18F]fluoro-L-dopa PET study
    Nurmi, E
    Ruottinen, HM
    Bergman, J
    Haaparanta, M
    Solin, O
    Sonninen, P
    Rinne, JO
    MOVEMENT DISORDERS, 2001, 16 (04) : 608 - 615
  • [4] The rate of progression of Parkinson's disease - A longitudinal [F-18]DOPA PET study
    Morrish, PK
    Sawle, GV
    Brooks, DJ
    PARKINSON'S DISEASE, 1996, 69 : 427 - 431
  • [5] Tremor at diagnosis is predictive of slower disease progression in Parkinson's disease:: An 18F DOPA PET study
    Whone, AL
    Brefel-Courbon, C
    Moore, RY
    Rascol, O
    Brooks, DJ
    MOVEMENT DISORDERS, 2002, 17 : S140 - S141
  • [6] An [F-18]dopa-PET and clinical study of the rate of progression in Parkinson's disease
    Morrish, PK
    Sawle, GV
    Brooks, DJ
    BRAIN, 1996, 119 : 585 - 591
  • [7] Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study
    Pavese, Nicola
    Rivero-Bosch, Maria
    Lewis, Stephanie J.
    Whone, Alan L.
    Brooks, David J.
    NEUROIMAGE, 2011, 56 (03) : 1463 - 1468
  • [8] Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-Dopa PET study
    Pavese, N.
    Rivero-Bosch, M.
    Lewis, S. J.
    Brooks, D. J.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S154 - S154
  • [9] Corticostriatal covariance patterns of 6–[18F]fluoro–L–dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease
    V. Kaasinen
    R. P. Maguire
    H.–P. Hundemer
    K. L. Leenders
    Journal of Neurology, 2006, 253 : 340 - 348
  • [10] An 18F dopa PET study of disease progression and subclinical nigrostriatal dysfunction in a Parkin kindred
    Khan, NL
    Pavese, N
    Wood, NW
    Lees, AJ
    Brooks, DJ
    Piccini, P
    NEUROLOGY, 2001, 56 (08) : A249 - A249
12345